IL-2 Heat Stable Agonist: Engineered with enhanced thermal stability and altered receptor affinity for improved biological activity, ideal for cellular therapy applications such as CAR T-cell or Tumor ...

The biotech group struggled as a whole in 2024, but analysts say the innovation that has always supported the biotech ...

Shares of Bio-Techne Corp. TECH inched 0.40% higher to $73.03 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.10% to ...

Shares of Bio-Techne Corp. TECH slumped 0.59% to $72.74 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.73% to 5,974. ...

MINNEAPOLIS - Bio-Techne (NASDAQ:TECH) Corporation (NASDAQ: TECH), a provider of automated platforms for biotherapeutic characterization with a market capitalization of $11.35 billion, announced today ...

(RTTNews) - Bio-Techne Corporation (TECH), a provider of life science reagents, instruments and services, Thursday announced a co-marketing and co-promotion agreement with Waters Corporation to ...

Bio-Techne (TECH) announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced biotherapeutic characterization and development processes.

MINNEAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leader in automated platforms for biotherapeutic characterization, today announced a co-marketing and co ...

5] Click on the 'Search' button. Your Hamps Bio IPO allotment status will become available on your computer monitor or your cell phone screen.